MX2016013340A - Metodos para tratar hipersomnia. - Google Patents
Metodos para tratar hipersomnia.Info
- Publication number
- MX2016013340A MX2016013340A MX2016013340A MX2016013340A MX2016013340A MX 2016013340 A MX2016013340 A MX 2016013340A MX 2016013340 A MX2016013340 A MX 2016013340A MX 2016013340 A MX2016013340 A MX 2016013340A MX 2016013340 A MX2016013340 A MX 2016013340A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- treating hypersomnia
- hypersomnia
- treating
- channel blocker
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
En la presente se proporcionan los métodos, formulaciones y regímenes de dosificación para tratar hipersomnia en un individuo. Por ejemplo, los métodos que se proporcionan en la presente comprenden la administración de un bloqueador del canal de cloruro GABAA. En ciertas modalidades, el bloqueador del canal de cloruro GABAA es pentilenotetrazol (PTZ).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461979918P | 2014-04-15 | 2014-04-15 | |
PCT/US2015/025696 WO2015160766A1 (en) | 2014-04-15 | 2015-04-14 | Methods for treating hypersomnia |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2016013340A true MX2016013340A (es) | 2017-02-09 |
Family
ID=54324484
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2016013340A MX2016013340A (es) | 2014-04-15 | 2015-04-14 | Metodos para tratar hipersomnia. |
Country Status (12)
Country | Link |
---|---|
US (3) | US10688103B2 (es) |
EP (1) | EP3131904A4 (es) |
JP (2) | JP6672264B2 (es) |
KR (1) | KR20170005415A (es) |
CN (1) | CN106459066B (es) |
AU (2) | AU2015247829B2 (es) |
CA (1) | CA2945705A1 (es) |
EA (1) | EA201692061A1 (es) |
IL (1) | IL248255A0 (es) |
MX (1) | MX2016013340A (es) |
WO (1) | WO2015160766A1 (es) |
ZA (1) | ZA201607068B (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10278977B2 (en) | 2016-06-06 | 2019-05-07 | Umecrine Cognition Ab | Methods for treating hypersomnolence |
WO2018209119A1 (en) * | 2017-05-10 | 2018-11-15 | Emory University | Treatment of conditions associated with myotonic dystrophy |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006137746A (ja) | 2004-10-13 | 2006-06-01 | Otsuka Pharmaceut Factory Inc | オレキシン誘導組成物 |
DK2032987T3 (en) | 2006-05-22 | 2016-04-25 | Univ Leland Stanford Junior | Pharmacological treatment of Cognitive impairment |
US20110038850A1 (en) | 2007-01-05 | 2011-02-17 | Didier Bagnol | G Protein-Coupled Receptor and Modulators Thereof For The Treatment of Gaba-Related Neurological Disorders Including Sleep-Related Disorders |
AU2009223153A1 (en) * | 2008-03-12 | 2009-09-17 | Emory University | Use of GABAa receptor antagonists for the treatment of excessive sleepiness and disorders associated with excessive sleepiness |
US20090325999A1 (en) * | 2008-06-27 | 2009-12-31 | Jie Du | Personalized pharmaceutical kits, packaging and compositions for the treatment of allergic conditions |
US8946206B2 (en) * | 2010-12-17 | 2015-02-03 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for improving cognitive function |
CN103502224A (zh) | 2011-02-23 | 2014-01-08 | 克鲁莱斯有限公司 | 氟马西尼络合物、包含该络合物的组合物及其用途 |
MX362218B (es) * | 2011-05-04 | 2019-01-09 | Balance Therapeutics Inc | Derivados de pentilentetrazol. |
-
2015
- 2015-04-14 AU AU2015247829A patent/AU2015247829B2/en not_active Ceased
- 2015-04-14 CA CA2945705A patent/CA2945705A1/en not_active Abandoned
- 2015-04-14 KR KR1020167031237A patent/KR20170005415A/ko not_active Application Discontinuation
- 2015-04-14 US US15/303,725 patent/US10688103B2/en active Active
- 2015-04-14 JP JP2017506256A patent/JP6672264B2/ja not_active Expired - Fee Related
- 2015-04-14 CN CN201580031853.4A patent/CN106459066B/zh not_active Expired - Fee Related
- 2015-04-14 EA EA201692061A patent/EA201692061A1/ru unknown
- 2015-04-14 MX MX2016013340A patent/MX2016013340A/es unknown
- 2015-04-14 EP EP15780466.7A patent/EP3131904A4/en not_active Withdrawn
- 2015-04-14 WO PCT/US2015/025696 patent/WO2015160766A1/en active Application Filing
-
2016
- 2016-10-09 IL IL248255A patent/IL248255A0/en unknown
- 2016-10-13 ZA ZA2016/07068A patent/ZA201607068B/en unknown
-
2019
- 2019-11-22 AU AU2019268190A patent/AU2019268190A1/en not_active Abandoned
-
2020
- 2020-03-04 JP JP2020036646A patent/JP2020105200A/ja active Pending
- 2020-05-06 US US16/868,365 patent/US20200360398A1/en not_active Abandoned
-
2022
- 2022-12-13 US US18/080,079 patent/US20230115839A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
JP6672264B2 (ja) | 2020-03-25 |
CA2945705A1 (en) | 2015-10-22 |
IL248255A0 (en) | 2016-11-30 |
EP3131904A1 (en) | 2017-02-22 |
US20200360398A1 (en) | 2020-11-19 |
US10688103B2 (en) | 2020-06-23 |
US20180169107A1 (en) | 2018-06-21 |
ZA201607068B (en) | 2023-01-25 |
US20230115839A1 (en) | 2023-04-13 |
JP2017511386A (ja) | 2017-04-20 |
KR20170005415A (ko) | 2017-01-13 |
EA201692061A1 (ru) | 2017-03-31 |
EP3131904A4 (en) | 2017-11-22 |
CN106459066A (zh) | 2017-02-22 |
JP2020105200A (ja) | 2020-07-09 |
WO2015160766A1 (en) | 2015-10-22 |
AU2015247829A1 (en) | 2016-10-27 |
AU2019268190A1 (en) | 2019-12-12 |
CN106459066B (zh) | 2020-07-07 |
AU2015247829B2 (en) | 2019-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1254534A1 (zh) | 路徑生成程序、路徑生成方法和路徑生成裝置 | |
MX2017003022A (es) | Anticuerpos anti-cll-1 e inmunoconjugados. | |
PL3110975T3 (pl) | Metody analizy somatycznych elementów ruchomych i ich zastosowania | |
ZA201608164B (en) | Systems, apparatus, and methods for generating and analyzing resistome profiles | |
SG11201605692WA (en) | Audio processing device and method, and program therefor | |
GB2543202B (en) | Well ranging apparatus, methods, and systems | |
EP3073705A4 (en) | CHANNEL MANUFACTURING METHOD AND DEVICE | |
EP3125221A4 (en) | Encryption processing device, and encryption processing method and program | |
IL281682A (en) | Roller kit, pipe components and method | |
ZA201703498B (en) | Kcnq2-5 channel activator | |
RS64708B1 (sr) | Benzoimidazol-1,2-il amidi kao aktivatori kv7 kanala | |
HK1217999A1 (zh) | 安檢通道以及安檢裝置 | |
GB2549200B (en) | Well ranging apparatus, methods and systems | |
EP3106218A4 (en) | Carbon-dioxide capturing material, and carbon-dioxide recovery apparatus using same | |
MX2016009537A (es) | Metodo para tratar ropa. | |
JO3541B1 (ar) | علاجات طبية قائمة على اناموريلين | |
AU2019268190A1 (en) | Methods for treating hypersomnia | |
GB201405715D0 (en) | Methods, apparatus and materials | |
GB201720695D0 (en) | Irrigation apparatus and feeding system | |
SG11201702148RA (en) | Acrylic acid-based copolymer, method for producing same and water treatment agent | |
GB201400767D0 (en) | Devices, systems and methods for the whitening of teeth | |
PH12017500071A1 (en) | Therapeutic agent for keratoconjunctive disorder | |
ZA201605538B (en) | Channel decoding method and apparatus, and distributed decoder | |
MX2016009541A (es) | Metodo para tratar vajilla. | |
SG11201608082XA (en) | Agent for regulating melatonin secretion, and method for regulating melatonin secretion |